Sufficient sleep is critical for health in older adults, but prescription sleep aids are associated with numerous health risks (e.g., cognitive impairment and falls). We examine usage prevalence of two medication categories—sedative hypnotics (SH) and medications commonly used for insomnia (MCUFI)—among adults aged 45+ in the National Alzheimer’s Coordinating Center data set. Analyzing the visits conducted between September 2005 and June 2018, we determine the factors associated with SH and MCUFI use, including sociodemographic, health, independence, and cognitive statuses. Usage rates were 9% for MCUFI (N = 3,279) and 4% for SH (N = 1,382). Multivariable logistic regression identified White race, higher education, younger age, depression, and sedative polypharmacy as factors associated with prescription sleep aid use. We conclude that sleep medication usage rates among older adults, higher likelihood of sedative medication polypharmacy, and higher likelihood of MCUFI use among adults with cognitive impairment are findings of concern and may warrant clinical intervention.
American Geriatrics Society Beers Criteria Update Expert Panel. (2015). American geriatrics society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 63(11), 2227–2246. https://doi.org/10.1111/jgs.13702
2.
American Geriatrics Society Beers Criteria Update Expert Panel. (2019). American geriatrics society 2019 updated AGS Beers criteria(R) for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 67(4), 674–694. https://doi.org/10.1111/jgs.15767
3.
Ancoli-IsraelS.RothT. (1999). Characteristics of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey I. Sleep, 22(Suppl. 2), S347–S353.
4.
AparasuR. R.MortJ. R.BrandtH. (2003). Psychotropic prescription use by community-dwelling elderly in the United States. Journal of the American Geriatrics Society, 51(5), 671–677.
5.
AvidanA. Y.FriesB. E.JamesM. L.SzafaraK. L.WrightG. T.ChervinR. D. (2005). Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes. Journal of the American Geriatrics Society, 53(6), 955–962. https://doi.org/10.1111/j.1532-5415.2005.53304.x
6.
BarbeeH.MoloneyM.KonradT. (2018). Selling slumber: American neoliberalism and the medicalization of sleeplessness. Sociology Compass, 12(10), Article e12622. https://doi.org/10.1111/soc4.12622
7.
BartonC.KetelleR.MerrileesJ.MillerB. (2016). Non-pharmacological management of behavioral symptoms in frontotemporal and other dementias. Current Neurology and Neuroscience Reports, 16(2), 14. https://doi.org/10.1007/s11910-015-0618-1
8.
BeeklyD. L.RamosE. M.LeeW. W.DeitrichW. D.JackaM. E.WuJ.HubbardJ. L.KoepsellT. D.MorrisJ. C.KukullW. A., & NIA Alzheimer’s Disease Centers. (2007). The National Alzheimer’s Coordinating Center (NACC) database: The Uniform Data Set. Alzheimer Disease and Associated Disorders, 21(3), 249–258. https://doi.org/10.1097/WAD.0b013e318142774e
9.
BeeklyD. L.RamosE. M.van BelleG.DeitrichW.ClarkA. D.JackaM. E.KukullW. A., & NIA Alzheimer’s Disease Centers. (2004). The National Alzheimer’s Coordinating Center (NACC) Database: An Alzheimer disease database. Alzheimer Disease and Associated Disorders, 18(4), 270–277.
10.
BellJ. S.MezraniC.BlackerN.LeBlancT.FrankO.AdermanC. P.RossiS.RowettD.ShuteR. (2011). Anticholinergic and sedative medications: Prescribing considerations for people with dementia. Australian Family Physician, 41(1–2), 45–49.
11.
BertischS. M.HerzigS. J.WinkelmanJ. W.BuettnerC. (2014). National use of prescription medications for insomnia: NHANES 1999-2010. Sleep, 37(2), 343–349. https://doi.org/10.5665/sleep.3410
12.
Biolloti de GageS.MorideY.DucreuetT.KurthT.VerdouxH.TournierM.ParienteT.BegaudB. (2014). Benzodiazepine use and risk of Alzheimer’s disease: A case control study. British Medical Journal, 349, Article g5205. https://doi.org/10.1136/bmj.g5205
CouplandC. A. C.HillT.DeningT.MorrissR.MooreM.Hippisley-CoxJ. (2019). Anticholinergic drug exposure and the risk of dementia: A nested case-control study. JAMA Internal Medicine, 179(8), 1084-1093.
15.
EllulJ.ArcherN.FoyC. M.PoppeM.BoothbyH.NicholasH.BrownR. G.LovestoneS. (2007). The effects of commonly prescribed drugs in patients with Alzheimer’s disease on the rate of deterioration. Journal of Neurology, Neurosurgery, and Psychiatry, 78(3), 233–239. https://doi.org/10.1136/jnnp.2006.104034
16.
FordE. S.WheatonA. G.CunninghamT. J.GilesW. H.ChapmanD. P.CroftJ. B. (2014). Trends in outpatient visits for insomnia, sleep apnea, and prescriptions for sleep medications among US adults: Findings from the National Ambulatory Medical Care survey 1999-2010. Sleep, 37(8), 1283–1293. https://doi.org/10.5665/sleep.3914
17.
GallegosA. M.MoynihanJ.PigeonW. R. (2016). A secondary analysis of sleep quality changes in older adults from a randomized trial of an MBSR program. Journal of Applied Gerontology, 37(11), 1327–1343.
18.
GarciaR. M. (2006). Five ways you can reduce inappropriate prescribing in the elderly: A systematic review. Journal of Family Practice, 55(4), 305–312.
19.
GlassJ.LanctôtK. L.HerrmannN.SprouleB. A.BustoU. E. (2005). Sedative hypnotics in older people with insomnia: Meta-analysis of risks and benefits. British Medical Journal, 331(7526), Article 1169. https://doi.org/10.1136/bmj.38623.768588.47
20.
GrandnerM. (2019). Sleep and health (1st ed.). Elsevier.
21.
KripkeD. F. (2016). Hypnotic drug risks of mortality, infection, depression, and cancer: But lack of benefit. F1000Research, 5, Article 918. https://doi.org/10.12688/f1000research.8729.3
22.
KripkeD. F.LangerR. D.KlineL. E. (2012). Hypnotics’ association with mortality or cancer: A matched cohort study. BMJ Open, 2(1), Article e000850. https://doi.org/10.1136/bmjopen-2012-000850
23.
LeggettA.PepinR.SonnegaA.AssariS. (2016). Predictors of new onset sleep medication and treatment utilization among older adults in the United States. The Journals of Gerontology, Series A: Biological Sciences & Medical Sciences, 71(7), 954–960. https://doi.org/10.1093/gerona/glv227
24.
MinY.SlattumP. W. (2018). Poor sleep and risk of falls in community-dwelling older adults: A systematic review. Journal of Applied Gerontology, 37(9), 1059–1084. https://doi.org/10.1177/0733464816681149
25.
MitchellM. D.GehrmanP.PerlisM.UmscheidC. A. (2012). Comparative effectiveness of cognitive behavioral therapy for insomnia: A systematic review. BMC Family Practice, 13, 40. https://doi.org/10.1186/1471-2296-13-40
26.
MogaD. C.AbnerE. L.RigsbyD. N.EckmannL.HuffmyerM.MurphyR. R.CoyB. B.JichaG. A. (2017). Optimizing medication appropriateness in older adults: A randomized clinical interventional trial to decrease anticholinergic burden. Alzheimer’s Research & Therapy, 9(1), 36. https://doi.org/10.1186/s13195-017-0263-9
27.
MogaD. C.AbnerE. L.WuQ.JichaG. A. (2017). Bladder antimuscarinics and cognitive decline in elderly patients. Alzheimer’s & Dementia, 3(1), 139–148. https://doi.org/10.1016/j.trci.2017.01.003
28.
MoloneyM.CiciurkaiteG.BrownR. (2019). The medicalization of sleeplessness: Results of U.S. office visit outcomes, 2008-2015. SSM—Population Health, 8, 100388. https://doi.org/10.1016/j.ssmph.2019.100388
29.
MoloneyM.KonradT.ZimmerC. (2011). The medicalization of sleeplessness: A public health concern. American Journal of Public Health, 101(8), 1429–1433. https://doi.org/10.2105/AJPH.2010.300014
MorganS. G.WeymannD.PrattB.SmolinaK.GladstoneE. J.RaymondC.MintzesB. (2016). Sex differences in the risk of receiving potentially inappropriate prescriptions among older adults. Age and Ageing, 45(4), 535–542. https://doi.org/10.1093/ageing/afw074
32.
MorrisJ.WeintraubS.ChuiH.CummingsJ.DecarliC.FerrisS.FosterN. L.GalaskoD.Graff-RadfordN.PeskindE. R.BeeklyD.RamosE. M.KukullW. (2006). The Uniform Data Set (UDS): Clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Disease and Associated Disorders, 20(4), 210–216. https://doi.org/10.1097/01.wad.0000213865.09806.92
33.
NeikrugA. B.Ancoli-IsraelS. (2010). Sleep disorders in the older adult—A mini-review. Gerontology, 56, 181–189.
34.
O’BryantS. E.WaringS. C.CullumC. M.HallJ.LacritzL.MassmanP. J.LupoP. J.ReischJ. S.DoodyR.Texas Alzheimer’s ResearchC. (2008). Staging dementia using clinical dementia rating scale sum of boxes scores: A Texas Alzheimer’s research consortium study. Archives of Neurology, 65(8), 1091–1095. https://doi.org/10.1001/archneur.65.8.1091
35.
QaseemA.KansagaraD.ForcieaM. A.CookeM.DenbergT. D., & Clinical Guidelines Committee of the American College o f Physicians. (2016). Management of chronic insomnia disorder in adults: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 165(2), 125–133. https://doi.org/10.7326/M15-2175
36.
RamseyC. M.GnjidicD.AgogoG. O.AlloreH.MogaD. (2018). Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimer’s & Dementia, 4, 1–10. https://doi.org/10.1016/j.trci.2017.10.008
37.
RasuR. S.ShenolikarR. A.NahataM. C.BalkrishnanR. (2005). Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: An analysis of data from the National Ambulatory Medical Care Survey for 1996-2001. Clinical Therapeutics, 27(12), 1970–1979. https://doi.org/10.1016/j.clinthera.2005.12.008
38.
SadowskyC. H.GalvinJ. E. (2012). Guidelines for the management of cognitive and behavioral problems in dementia. Journal of the American Board of Family Medicine, 25(3), 350–366. https://doi.org/10.3122/jabfm.2012.03.100183
39.
SAS Institute Inc. (2017). SAS 9.4. (Original work published 2013)
40.
TannenbaumC.MartinP.TamblynR.BenedettiA.AhmedS. (2014). Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: The EMPOWER cluster randomized trial. JAMA Internal Medicine, 174(6), 890–898. https://doi.org/10.1001/jamainternmed.2014.949
41.
TrevesN.PerlmanA.Kolenberg GeronL.AsalyA.MatokI. (2018). Z-drugs and risk for falls and fractures in older adults: A systematic review and meta-analysis. Age and Ageing, 47(2), 201–208. https://doi.org/10.1093/ageing/afx167
42.
van der SpekK.KoopmansR.SmalbruggeM.Nelissen-VranckenM.WetzelsR. B.SmeetsC. H. W.de VriesE.TeerenstraS.ZuidemaS. U.GerritsenD. L. (2018). The effect of biannual medication reviews on the appropriateness of psychotropic drug use for neuropsychiatric symptoms in patients with dementia: A randomised controlled trial. Age and Ageing, 47(3), 430–437. https://doi.org/10.1093/ageing/afy001
43.
WeichS.PearceH. L.CroftP.SinghS.CromeI.BashfordJ.FrisherM. (2014). Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: Retrospective cohort study. British Medical Journal, 348, Article g1996. https://doi.org/10.1136/bmj.g1996
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
